Search - tctmd.com

Displaying 941 - 960 of 2954

Sort: Relevancy | Date

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Kengo Tanabe

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Patrick W. Serruys

September 22, 2018

$Case Study: Mechanism and Treatment of Refractory ISR$

Presentation TCT 2018

Case Study: Mechanism and Treatment of Refractory ISR

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

Presentation TCT 2018

Considerations for LAA Closure Devices: FDA Perspective

Presenter: Andrew Farb

September 22, 2018

$Role of Brachytherapy for Refractory ISR in 2018$

Presentation TCT 2018

Role of Brachytherapy for Refractory ISR in 2018

Presenter: Fernando Alfonso, Azeem Latib, Ron Waksman

September 22, 2018

Presentation TCT 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Presenter: Fernando Alfonso, Azeem Latib, Juan F. Granada

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

Presenter: Akihide Konishi

September 22, 2018

Presentation TCT 2018

Chronic Oral Anticoagulation After Stenting: Strategy in Belarus

Presenter: Walter Desmet, Guy J. Friedrich, Oleg Polonetsky

September 22, 2018

Presentation TCT 2018

Case #5: From South Korea: Tear of a Calcified Coronary Artery

Presenter: Vinay K. Bahl, Huay Cheem Tan, Jun-Jack Cheng, Kenneth Chin, Jeehoon Kang, Sreenivas Arramraju Kumar, Linda Lison, Fazila T. Malik

September 22, 2018

Presentation TCT 2018

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Presenter: Alfredo Trento

September 22, 2018

Presentation TCT 2018

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

Presenter: Fernando Alfonso, Azeem Latib, Bruno Scheller

September 22, 2018

Presentation TCT 2018

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Presenter: Marek Grygier

September 22, 2018

Presentation TCT 2018

Case #4: From Singapore: Finding a Missing Bioresorbable Scaffold

Presenter: Vinay K. Bahl, Huay Cheem Tan, Jun-Jack Cheng, Kenneth Chin, Jeehoon Kang, Sreenivas Arramraju Kumar, Linda Lison, Fazila T. Malik

September 22, 2018

Presentation TCT 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Presenter: Fernando Alfonso, Azeem Latib

September 22, 2018

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

Presentation TCT 2018

Is There Still a Role for Triple Therapy Based on Recent Studies?

Presenter: Walter Desmet, Guy J. Friedrich

September 22, 2018

Presentation TCT 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presenter: Fernando Alfonso, Azeem Latib, Antonio Colombo

September 22, 2018

Presentation TCT 2018

Case Study: Mechanism and Treatment of Stent Thrombosis

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

Presentation TCT 2018

Can Intracoronary Imaging Guide Antithrombotic Strategy?

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic

September 22, 2018

Presentation TCT 2018

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Presenter: Fernando Alfonso, Azeem Latib, Robert A. Byrne

September 22, 2018

Advertisement

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

Case Study: Mechanism and Treatment of Refractory ISR

Considerations for LAA Closure Devices: FDA Perspective

Role of Brachytherapy for Refractory ISR in 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

Chronic Oral Anticoagulation After Stenting: Strategy in Belarus

Case #5: From South Korea: Tear of a Calcified Coronary Artery

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Case #4: From Singapore: Finding a Missing Bioresorbable Scaffold

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Is There Still a Role for Triple Therapy Based on Recent Studies?

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Case Study: Mechanism and Treatment of Stent Thrombosis

Can Intracoronary Imaging Guide Antithrombotic Strategy?

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content